RNA Q2 2023 Earnings — Avidity Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

RNAAvidity Biosciences, Inc.

$2B

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+6.3% YoY

Gross Profit

-$40M-1742.5% margin

Operating Income

-$53M-2272.6% margin

Net Income

-$47M-2030.4% margin

EPS (Diluted)

$-0.66

QoQ Revenue Growth

+3.7%

Cash Flow

Operating Cash Flow

-$50M

Free Cash Flow

-$50M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$611M

Total Liabilities

$52M

Stockholders' Equity

$559M

Cash & Equivalents

$154M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	+6.3%
Gross Profit	-$40M	-$38M	-7.3%
Operating Income	-$53M	-$46M	-13.7%
Net Income	-$47M	-$46M	-2.9%